Robert Amdur is an Oncology physician affiliated with UF Health Shands Hospital. OpenAlex indexes 563 publications with 16,013 citations (h-index 65); ClinicalTrials.gov lists 5 registered studies matched to this name. By OpenAlex citation count, this profile ranks in the top 10% of Radiation Oncology profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1600 SW Archer Rd
Gainesville, FL 326103003
Telephone
352-265-0287Registry record last updated 28 Dec 2011.
Clinical trials
- Risk Adapted De-Intensification of Radio-Chemotherapy for Oropharyngeal Squamous Cell Carcinoma
Sponsor: University of Florida
- Radiotherapy Dose Escalation in Locally Advanced Squamous Cell Carcinoma of the Larynx or Hypopharynx
Sponsor: University of Florida
- Caphosol for the Reduction of Mucositis in Patients Receiving Radiation Therapy for Head and Neck Cancer
Sponsor: Jazz Pharmaceuticals
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
50.5%Opioid Agonist29.7%Tramadol Hcl52%Oxycodone Hcl49%Part D<11 patientsGabapentinoids20.7%Gabapentin100%Part D<11 patientsCardiovascular
32.4%Blood Viscosity Reducer20.7%Pentoxifylline100%Part D<11 patientsAntiarrhythmic11.7%Lidocaine Hcl Viscous100%Part D<11 patientsSensory organs
17.1%Other antiinfectives17.1%Chlorhexidine Gluconate100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Plasma Circulating Tumor HPV DNA for the Surveillance of Cancer Recurrence in HPV-Associated Oropharyngeal Cancer
Journal of Clinical Oncology
2020 - Phase II Trial of De-Intensified Chemoradiotherapy for Human Papillomavirus–Associated Oropharyngeal Squamous Cell Carcinoma
Journal of Clinical Oncology
2019 - Consensus guidelines for postoperative stereotactic body radiation therapy for spinal metastases: results of an international survey
Journal of Neurosurgery Spine
2016
Similar KOLs
Other experts from the same institution or the same specialty.
Richard Neiberger, MD, PhD
UF Health Shands Hospital
Lance Governale, MD
UF Health Shands Hospital
Siddharth Wayangankar, MD
UF Health Shands Hospital
Renata Shih, MD
UF Health Shands Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”